Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease. - Honig, Lawrence S.; Sabbagh, Marwan N.; van Dyck, Christopher H.; Sperling, Reisa A.; Hersch, Steven; Matta, Andre; Giorgi, Luigi; Gee, Michelle; Kanekiyo, Michio; Li, David; Purcell, Derk; Dhadda, Shobha; et al. (Alzheimer's Research & Therapy, 2024)